Philip Morris International Inc (PM) Covered Calls

Philip Morris International Inc covered calls Philip Morris International Inc. is a leading global tobacco company working toward a smoke-free future. The company specializes in the manufacture and sale of cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine offerings. Headquartered in Stamford, Connecticut, and listed on the NYSE, PMI is diversifying its portfolio to include wellness and healthcare products while transitioning away from traditional combustible tobacco products.

You can sell covered calls on Philip Morris International Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PM (prices last updated Thu 4:16 PM ET):

Philip Morris International Inc (PM) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
188.95 +2.68 188.89 190.00 5.5M 26 290
Covered Calls For Philip Morris International Inc (PM)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Feb 20 190 2.00 188.00 1.1% 44.6%
Mar 20 190 5.10 184.90 2.8% 27.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Core Business and Products

Philip Morris International (PMI) is the global leader in the tobacco industry’s transformation toward reduced-risk alternatives. As of early 2026, the company has implemented a major organizational restructuring, creating dedicated "International Smoke-Free," "International Combustibles," and "U.S." business units. This shift reflects PMI’s goal to become a substantially smoke-free company by 2030, with over two-thirds of its revenue expected to come from non-combustible products.

  1. Heat-Not-Burn (IQOS): The flagship IQOS platform is the world’s leading heated tobacco product. In 2026, PMI is focused on the broad U.S. launch of "IQOS ILUMA," which utilizes induction heating technology. IQOS currently serves over 30 million users globally who have switched completely from cigarettes.
  2. Oral Nicotine (ZYN): Following the acquisition of Swedish Match, ZYN has become a massive growth engine. In 2026, PMI is aggressively expanding ZYN’s production capacity to meet unprecedented demand in the U.S. and is pursuing FDA authorization to market it as a "Modified Risk Tobacco Product" (MRTP).
  3. Combustibles: While transitioning, PMI still maintains the world’s most valuable cigarette brand, Marlboro (outside the U.S.), alongside Chesterfield and L&M. This segment provides the significant cash flow necessary to fund the company’s $14 billion+ R&D investment in smoke-free tech.
  4. Wellness and Healthcare: Through its "Aspeya" unit, PMI is developing inhaled therapeutics and respiratory health solutions, leveraging its expertise in aerosol chemistry and life sciences.

Competitive Landscape

The nicotine market in 2026 is a high-stakes battle between traditional tobacco giants and fast-moving vapor specialists:

  1. Global Multi-Category Rivals: PMI’s most direct international competitor is British American Tobacco (BAT), which competes across vapes (Vuse), heated tobacco (glo), and pouches (Velo).
  2. U.S. Market Dynamics: In the United States, PMI is now a direct competitor to its former parent, Altria Group. While Altria holds the U.S. rights to Marlboro, PMI is challenging them with IQOS and leading the pouch category with ZYN.
  3. Regional and Specialized Peers: Japan Tobacco International (JTI) remains a formidable rival in Asian and European markets. In the cannabis and alternative nicotine space, PMI monitors players like Cronos Group.

Strategic Outlook and Innovation

Entering February 2026, PMI is at a "tipping point." Smoke-free products now account for roughly 42% of total net revenues. A key strategic priority for the year is the "U.S. Acceleration Plan," which aims to capture a 10% share of the U.S. cigarette market through IQOS conversion within the next five years. Innovation is highlighted by the "VEEV" e-vapor platform’s integration of AI-driven dosage control to enhance safety and user experience. Despite regulatory headwinds and excise tax pressures, PMI maintains industry-leading operating margins near 37%. With a robust dividend yield and a clear path toward phasing out cigarettes in several key markets, Philip Morris International is positioning itself as the definitive "ESG-transition" story within the consumer staples sector.